Metraipolis › archive › dc_c4ad952b04cd

Targeting leucine-rich alpha-2-glycoprotein-1 (LRG1) and the LRG1-cytochrome c-Apaf-1 axis in cancer therapy — Europe PMC PMID:42540433

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42540433
DOI
10.18632/oncoscience.667
License (as archived)
solo-consultazione
Archived
2026-10-17T10:49:50.191Z
SHA-256 of the archived text
ce29f3946a73c15c6fb9e65dd94da75c4943dc3d9c51537cfb93ea2723a0d5bf
Stable URL of this page
https://metraipolis.com/documento/dc_c4ad952b04cd

How to cite

Targeting leucine-rich alpha-2-glycoprotein-1 (LRG1) and the LRG1-cytochrome c-Apaf-1 axis in cancer therapy — Europe PMC PMID:42540433 — Europe PMC (en), https://europepmc.org/article/MED/42540433 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4ad952b04cd (Metraipolis archive dc_c4ad952b04cd, sha256 ce29f3946a73c15c6fb9e65dd94da75c4943dc3d9c51537cfb93ea2723a0d5bf)
BibTeX
@misc{dcc4ad952b04cd,
  title = {Targeting leucine-rich alpha-2-glycoprotein-1 (LRG1) and the LRG1-cytochrome c-Apaf-1 axis in cancer therapy — Europe PMC PMID:42540433},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42540433},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4ad952b04cd; sha256 ce29f3946a73c15c6fb9e65dd94da75c4943dc3d9c51537cfb93ea2723a0d5bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42540433. Agents can read the archived copy with the MCP tool read_document.